ArticleScientific reports2017

In vivo evaluation of a novel format of a bivalent HER3-targeting and albumin-binding therapeutic affibody construct.

Tarek Z Bass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.